title: [Diaphragmatic surgery in advanced ovarian cancer therapy].
abstract: OBJECTIVE
  Advanced ovarian cancer is a lethal disease. More than 75% of women with ovarian cancer are diagnosed in advanced stage FIGO IIIC-IV. The combination of surgical cytoreduction without residual tumor, and chemotherapy is the only way to prolong overall survival of women with advanced ovarian cancer.
  
  
  METHODS
  Systematic review.
  
  
  METHODS
  Current literature review.
  
  
  CONCLUSIONS
  Due to frequent involvement of the diaphragm in women with advanced ovarian cancer and the effort of optimal debulking is the inclusion of diaphragmatic surgery necessary for so affected women. Diaphragmatic surgery increases the rates of optimal cytoreduction, improves survival of women with advanced ovarian cancer and has acceptable morbidity rate.
authors.forename: V
authors.initials: V
authors.lastname: Kalist
authors.forename: P
authors.initials: P
authors.lastname: Havelka
authors.forename: M
authors.initials: M
authors.lastname: Mlčoch
authors.forename: Z
authors.initials: Z
authors.lastname: Adamík
authors.forename: J
authors.initials: J
authors.lastname: Klein
mesh_terms: D005260:Female; D006801:Humans; D018365:Neoplasm, Residual; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D017773:Pelvic Floor / Q000601:surgery*
keywords: advanced ovarian cancer; diaphragmatic surgery; optimal debulking; residual disease.